AESTHET SURG J 润色咨询

Aesthetic Surgery Journal

出版年份：1997 年文章数：2289 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：31.7% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2106107, encodeId=9bad210610e49, content=这是Q1还是Q2期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af253443582, createdName=1304e401m20暂无昵称, createdTime=Wed Dec 14 22:42:13 CST 2022, time=2022-12-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1104685, encodeId=2320110468528, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104686, encodeId=e98011046865e, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539715, encodeId=9b6d539e15fd, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530567, encodeId=2d9553056efe, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：不太难，比较喜欢长期疗效观察。总的来说，还是容易中的，但是国内投的太多，也缺乏长期疗效研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed Dec 14 10:26:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2022-12-14 1304e401m20暂无昵称 来自北京

    这是Q1还是Q2期刊

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2106107, encodeId=9bad210610e49, content=这是Q1还是Q2期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af253443582, createdName=1304e401m20暂无昵称, createdTime=Wed Dec 14 22:42:13 CST 2022, time=2022-12-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1104685, encodeId=2320110468528, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104686, encodeId=e98011046865e, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539715, encodeId=9b6d539e15fd, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530567, encodeId=2d9553056efe, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：不太难，比较喜欢长期疗效观察。总的来说，还是容易中的，但是国内投的太多，也缺乏长期疗效研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed Dec 14 10:26:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2021-12-27 小动量

    期刊给我发了一封信，但我看不懂怎么办？

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2106107, encodeId=9bad210610e49, content=这是Q1还是Q2期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af253443582, createdName=1304e401m20暂无昵称, createdTime=Wed Dec 14 22:42:13 CST 2022, time=2022-12-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1104685, encodeId=2320110468528, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104686, encodeId=e98011046865e, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539715, encodeId=9b6d539e15fd, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530567, encodeId=2d9553056efe, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：不太难，比较喜欢长期疗效观察。总的来说，还是容易中的，但是国内投的太多，也缺乏长期疗效研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed Dec 14 10:26:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2021-12-27 msSSSSSD

    期刊发送邮件中包括哪几个方面的内容？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2106107, encodeId=9bad210610e49, content=这是Q1还是Q2期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af253443582, createdName=1304e401m20暂无昵称, createdTime=Wed Dec 14 22:42:13 CST 2022, time=2022-12-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1104685, encodeId=2320110468528, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104686, encodeId=e98011046865e, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539715, encodeId=9b6d539e15fd, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530567, encodeId=2d9553056efe, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：不太难，比较喜欢长期疗效观察。总的来说，还是容易中的，但是国内投的太多，也缺乏长期疗效研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed Dec 14 10:26:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2017-07-18 chengqi2017

    一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2106107, encodeId=9bad210610e49, content=这是Q1还是Q2期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af253443582, createdName=1304e401m20暂无昵称, createdTime=Wed Dec 14 22:42:13 CST 2022, time=2022-12-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1104685, encodeId=2320110468528, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104686, encodeId=e98011046865e, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539715, encodeId=9b6d539e15fd, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530567, encodeId=2d9553056efe, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：不太难，比较喜欢长期疗效观察。总的来说，还是容易中的，但是国内投的太多，也缺乏长期疗效研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=289, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Wed Dec 14 10:26:00 CST 2016, time=2016-12-14, status=1, ipAttribution=)]
    2016-12-14 lovetcm

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享：不太难，比较喜欢长期疗效观察。总的来说，还是容易中的，但是国内投的太多，也缺乏长期疗效研究

    0

共9条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分